Celemics, Inc.

Publications

Celemics’ Publications

Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor

  • Post category:Oncology

Theranostics

Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor

Lee HJ, Pham PC, Pei H, Lim B, Hyun SY, Baek B, et al. Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor. Theranostics. 2021;11(4):1918–36.

 

10.7150/thno.48865